← All trials
NCT03706326
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 28, 2018
- Primary completion
- Sep 28, 2021
- Completion date
- Sep 28, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Guangdong Pharmaceutical UniversityLead sponsor
- Guangdong Pharmaceutical UniversityReponsible party - principal investigator
- Guangzhou Anjie Biomedical Technology Co., Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.